Mohit Malhotra: Immunising India with the Power of Ayurveda

The rise in COVID-19 cases indicates the second wave in India. The death rate due to COVID-19 has been recorded its highest since January this year according to the Union Health Ministry data. While a range of COVID vaccines have surged a relief, seeing the rise in COVID cases means people must take precautions and follow remedies and routines to build their immunity. Furthermore, the Ministry of AYUSH, India has suggested dietary measures that include turmeric milk, chyawanprash, and other ayurvedic herbs to prevent coronavirus infection.

This has led to a shift in consumer behavior towards using more Ayurveda and Natural Care immunity-boosting products. When it comes to the regular consumption of chyawanprash, Dabur has been the first choice for consumers in India.

With the company’s 136 years-long legacy and the motto of being ‘dedicated to the Health & Well-Being of every household’, the brand shares a strong bond of trust that has been immunizing millions of families in Indian households.

During the COVID crisis, the brand Dabur took an ambitious step to further immunize the trust among its consumers by undertaking a clinical study adhering to the GCP guidelines to test the immunity-boosting power of Dabur Chyawanprash.

The findings revealed that 1 out of 42, tested positive for COVID-19 in the control group who regularly consumed Dabur Chyawanprash. However, the control group who were not consuming Dabur Chyawanprash showed a 28.57% risk of infection with 28 out of 42 people testing positive for COVID-19.

This study has been registered with the Clinical Trials Registry of India, a portal of ICMR. The fact that the clinical study report proving the effectiveness of regular consumption of Dabur Chyawanprash to reduce the risk of coronavirus infection being approved by concerned institutional ethics committees further strengthening the trust among the Dabur consumers.

And for the CEO of Dabur, Mohit Malhotra who has been a career Daburite, this new immunity of trust is no less than a proud moment. Starting his career as a management trainee in 1994 to becoming the CEO of Dabur’s global operations, Mohit has had an enriching experience of impacting and touching the lives of millions in India.

“As a part of the marketing team during my initial years, I have been involved with the launch of several key brands for Dabur like Dabur Red Toothpaste and Vatika Hair Oil, both of which have grown to become Power Brands in Dabur’s brand architecture,” shares Mohit.

As Dabur started exploring international markets, Mohit took charge as the CEO of Dabur’s international business based in Dubai and under his leadership the brand Dabur has left a global footprint in over 100 countries.

In April 2019, Mohit stepped up as the CEO of Dabur’s global operations including India. and has led the company to be more agile, nimble-footed, and quick in execution, especially during the pandemic where the brand rolled out 50 slew products within three months of coronavirus outbreak. That shows the leader’s vision and the company’s efforts in R&D.

Read More: https://insightscare.com/mohit-malhotra-immunising-india-with-the-power-of-ayurveda/

Dominant Leaders to watch in Healthcare, 2021

The Indian healthcare space has endured a debilitating period that levied innumerable challenges upon every individual associated with the industry. Hospitals and healthcare service providers had to strive day in and day out to provide medical aid and care to all those affected by the COVID-19 pandemic.

Individuals in leadership positions had to take instant decisions to prioritize the timely delivery of appropriate medical care, all the while considering the safety of their staff and employees. One can only imagine the amount of experience and expertise that was demanded from these leaders at such crucial times. One such prominent leader in the Indian healthcare space is Dr. Devlina Chakravarty, the Managing Director and CEO of Artemis Hospital.

Dr. Devlina started her career in 1993 as a radiologist, trained from Mumbai University. She did fellowship/preceptorship programs from the University of Berlin (Germany), UCLA (Los Angeles), and Brigham & Women Hospital, Boston in Head and Neck & Body Imaging.

She worked as senior faculty and Programme Director in Radiology in different reputed hospitals in Delhi before joining Artemis in 2007. She strongly believes in ethical practices in healthcare and quality of service.

“At Artemis, I have tried to amalgamate my best learnings of international and domestic hospitals. Few things that I have always emphasized are ‘ethics and transparency, ‘profits without profiteering’, and an atmosphere of friendship and ownership in the hospital,” says Dr. Devlina.

Good medical outcomes, patient safety, infection control, and antimicrobial resistance are something close to her heart over and above creating great working environments for doctors and all other staff, through a transparent system of management.

Personalized tertiary care with service excellence continues to be her motto. Her dream is to create the most prestigious hospital in India with cutting-edge technology, best-in-class professionals, medical education, ethical and transparent practices.

Read More:  https://insightscare.com/dr-devlina-chakravarty-a-leading-name-in-the-indian-healthcare-space/